These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C. Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651 [Abstract] [Full Text] [Related]
6. A comparative review of the risks and benefits of hormone replacement therapy regimens. Warren MP. Am J Obstet Gynecol; 2004 Apr 20; 190(4):1141-67. PubMed ID: 15118656 [Abstract] [Full Text] [Related]
10. Unopposed estrogen therapy and the risk of invasive breast cancer. Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA. Arch Intern Med; 2006 May 08; 166(9):1027-32. PubMed ID: 16682578 [Abstract] [Full Text] [Related]
15. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view. Speroff L. Maturitas; 2004 Sep 24; 49(1):51-7. PubMed ID: 15351096 [Abstract] [Full Text] [Related]
16. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L, Dell'Aniello S, Assouline S, Suissa S. BJOG; 2008 Jan 24; 115(2):169-75; discussion 175. PubMed ID: 18081598 [Abstract] [Full Text] [Related]
18. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Bernstein L. Basic Clin Pharmacol Toxicol; 2006 Mar 24; 98(3):288-96. PubMed ID: 16611204 [Abstract] [Full Text] [Related]